CD86 and cancer: Immunohistochemical examination of cancer tissues and adjacent tissues from 60 patients with liver cancer showed that CD86, CD206, and PD-L1 were significantly stained in cancer tissues, as shown in Fig. 3, while statistical analysis showed a positive expression rate of PD-L1 of 57% in cancer tissues and 12% in adjacent tissues.